Quest Diagnostics (DGX) Change in Accured Expenses (2009 - 2026)

Quest Diagnostics has reported Change in Accured Expenses for 18 years, with the latest figure at $142.0 million in Q2 2026.

• Quarterly Change in Accured Expenses rose 238.1% year-over-year to $142.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $270.0 million (up 718.18% YoY) and the FY2025 annual result came in at $129.0 million, up 292.54% from the prior year.
• Change in Accured Expenses advanced to $142.0 million in Q2 2026 per DGX's latest filing, from -$12.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $176.0 million in Q4 2023 and troughed at -$211.0 million in Q1 2023.
• A 5-year average of -$666666.7 and a median of $18.0 million in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses surged 2100.0% in 2022, then sank 334.38% in 2023.
• Over 5 years, Change in Accured Expenses stood at $20.0 million in 2022, then jumped by 780.0% to $176.0 million in 2023, then plunged by 80.11% to $35.0 million in 2024, then plunged by 54.29% to $16.0 million in 2025, then soared by 787.5% to $142.0 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $142.0 million, -$12.0 million, and $16.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.